Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Creative Biogene

Creative Biogene is the leading global client service and solutions provider for scientific research, and is committed to the development, manufacture and purification of recombinant adenoviruses, adeno-associated virus (AAV) and lentivirus for gene delivery and gene knock down. With above 20 years of gene delivery tools development experience, Creative Biogene is specialized in providing gene delivery and gene knock down services that cover the full scope of biotechnology needs of early drug discovery and drug development.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

Creative Biogene
45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882
Contact Creative Biogene
Website

 Latest Content from PMHub 

Nucleus X Consulting – where patient engagement meets strategic consultancy

Press Releases | March 29, 2022 | Nucleus Global

Nucleus X Consulting consists of an agile team of specialists that combine expertise in all aspects of patient engagement along with strategic consultancy in rare disease and early-phase medical commercialisation.We...

Could I have a word please…?

White Papers and Resources | March 29, 2022 | Dice Medical Communications

Just how important is hard hitting copy?

Learning to invest in doctors’ education

White Papers and Resources | March 28, 2022 | M3 (EU)

Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for...

Top 10 Tips for Running a Successful Virtual Event

Videos and Podcasts | March 24, 2022 | Impetus Digital

As I explored in a recent article previously published on Pharmaphorum, the ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as...

Removing Barriers to Pharmaceutical Accessibility & Affordability Worldwide

Videos and Podcasts | March 24, 2022 | Impetus Digital

Dr. Dhiren Thakker, Founding President and CEO at Med Aditus, shares his insights into how blockchain and other leading-edge technologies can help revolutionize pharmaceutical manufacturing in sub-Saharan Africa and globally....

The Eleven guide to NFTs

Press Releases | March 24, 2022 | 11 London

Non-Fungible Tokens (NFTs) have been making waves in the news lately, specifically around the millions of dollars being exchanged for unique digital art assets. Investors have been queuing up to...

Extraordinary lives: advancing change in rare diseases (Part 2)

Press Releases | March 24, 2022 | Lucid Group Communications Limited

In support of Rare Disease Day, we’re excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

Extraordinary lives: advancing change in rare diseases (Part 2)

Videos and Podcasts | March 24, 2022 | Lucid Group Communications Limited

In support of Rare Disease Day, we're excited to launch part 2 of our video series; Extraordinary lives: advancing change in rare diseases.Why is raising awareness of rare diseases so...

The power of influence in transforming women’s health

White Papers and Resources | March 24, 2022 | Say Communications

Over the past four years HRT prescriptions have doubled in the UK, the cause was turbo charged by the action of celebrities and influencers.

KVA launch the KVA Mediverse, leading the way in VR healthcare comms

Press Releases | March 23, 2022 | KVA

KVA announce their new unique VR offering